Steven Gelone

Steven Gelone

No más puestos en curso
58 años
Health Technology
Consumer Services

Perfil

Steven P.
Gelone
is the founder of Hula Therapeutics, Inc. Former jobs include Director-Clinical Pharmacology at GSK Plc from 2000 to 2002, Director-Medical Affairs at Vicuron Pharmaceuticals LLC from 2002 to 2003, Vice President-Clinical & Preclinical Development at Shire ViroPharma, Inc. from 2005 to 2014, Chief Development Officer at Nabriva Therapeutics GmbH from 2014 to 2017, President, Chief Operating Officer & Director at Nabriva Therapeutics Plc from 2021 to 2023, and Head-Clinical Research & Development at Spark Therapeutics, Inc. Education includes undergraduate and doctorate degrees from Temple University (Pennsylvania).

Cargos activos de Steven Gelone

EmpresasCargoInicio

Antiguos cargos conocidos de Steven Gelone.

EmpresasCargoFin
Director Técnico/Científico/I+D 30/06/2017
Corporate Officer/Principal 01/01/2014
Director Técnico/Científico/I+D 01/01/2003
GSK PLC Director Técnico/Científico/I+D 01/01/2002
SPARK THERAPEUTICS, INC. Director Técnico/Científico/I+D -
Ver el detalle de la experiencia de Steven Gelone.

Formación de Steven Gelone.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

72

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology